Delivery Order SPE2DB22D3501-SPE2DB23FWC16
Award Date
6/20/23
Potential Completion Date
6/21/23
Potential Value
$303
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $421,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 180,000 units of ACAMPROSATE CALCIUM 333MG tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 12-13, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense and...
The Defense Logistics Agency awarded a $1,566 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 tablets of Acamprosate Calcium 333mg. The order is to be performed in Conshohocken, Pennsylvania by June 28, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its Corporate Office Division. The Defense Logistics Agency manages the global supply chain for the U.S. military and this order for...
This delivery order for $573 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp on October 11, 2023 for the delivery of 180 tablets of ACAMPROSATE CALC DR 333 MG to a location in Conshohocken, Pennsylvania. The order is to be completed by October 12, 2023 under a firm fixed price contract. No set-aside designation was applied to this award placed against an existing vehicle by the Defense Logistics Agency to procure pharmaceutical products in support of military...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,519.80 firm fixed price delivery order against the Defense Logistics Agency's Prime Vendor Program. Under this contract, Amerisourcebergen will provide 180 tablets of Acamprosate Calcium 333mg to a location in Conshohocken, Pennsylvania, with performance from June 26-27, 2023. The Defense Logistics Agency oversees logistics operations for the United States Department of Defense, working to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ACAMPROSATE CALC DR 333 MG TAB 180S. The contract is a Firm Fixed Price Delivery Order valued at $1,057.29 with a completion date of March 17, 2025. The contract is not designated as a set-aside and represents an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.59 Firm Fixed Price Delivery Order contract is for the supply of ACAMPROSATE CALC DR 333 MG TAB 180S, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,897.86 firm fixed-price delivery order is for the supply of 4,558,571,276 units of Acamprosate Calcium Delayed-Release 333 mg Tablets in a 180-count bottle. The award has an ultimate completion date of September 26, 2022 and was issued on September 23, 2022. No set-aside designation was used for this...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,455.70, is for the delivery of ACAMPROSATE CALC DR 333 MG TAB 180S, a medication used in the treatment of alcohol dependence. The contract has an ultimate completion date of March 6, 2025 and is a Firm Fixed Price Delivery Order. This contract is part of a larger Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX6WP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,755.18 firm fixed-price delivery order is for the supply of 180 tablets of Acamprosate Calcium delayed-release 333 mg. The contract has a completion date of December 12, 2023 and was awarded on December 11, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite...
The Defense Logistics Agency awarded a $25,760 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4562228321 under the agency's Prime Vendor Program. As the prime contractor, Amerisourcebergen will supply 28-day tablet packages of the specified medication to a facility located in Conshohocken, Pennsylvania between September 19-20, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply...